MENU
GALT
AS OF
Nov 19, 04:59 PM (EDT)
Price
$5.76
Change
-$0.43 (-6.95%)
Capitalization
371.36M
126 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galectin Therapeutics (GALT) Earnings Date & Reports

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

GALT is expected to report earnings to fall 23.08% to -10 cents per share on March 26

Galectin Therapeutics GALT Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.02
The last earnings report on November 14 showed earnings per share of -12 cents, beating the estimate of -18 cents. With 262.91K shares outstanding, the current market capitalization sits at 371.36M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GALT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GALT showed earnings on November 14, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GALT
A.I. Advisor
published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com